Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4185.40 +0.4% SILVER 57.12 −0.1% COPPER 6.56 +0.1% OIL 99.01 +1.1% PALLADIUM 1114.75 −1.2% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% BVA 0.780 +2.6% ONAU 0.530 +1.9% FMR 0.225 +0.0% GOLD 4185.40 +0.4% SILVER 57.12 −0.1% COPPER 6.56 +0.1% OIL 99.01 +1.1% PALLADIUM 1114.75 −1.2% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% BVA 0.780 +2.6% ONAU 0.530 +1.9% FMR 0.225 +0.0%

Healthcare

Page 64
  1. Feb 06, 2026 · 10:31 · VIVI

    Tempramed rolls out products to pharmacies in Israel

    Tempramed rolls out products to pharmacies in Israel

    01
  2. Feb 06, 2026 · 03:01 · VIVI

    TempraMed Launches National Brick and Mortar Pharmacy Roll Out, Shipping Products to Maccabi Pharmacies Across Israel

    TempraMed Launches National Brick and Mortar Pharmacy Roll Out, Shipping Products to Maccabi Pharmacies Across Israel

    02
  3. Feb 05, 2026 · 18:29 · PRN

    Profound sees Polish hospital complete 500th procedure

    Profound sees Polish hospital complete 500th procedure

    03
  4. Feb 05, 2026 · 18:00 · SKNY

    LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories

    LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories

    04
  5. Feb 05, 2026 · 17:16 · NGMD

    NuGen Medical Devices Inc. Provides Update on Health Canada License

    NuGen Medical Devices Inc. Provides Update on Health Canada License

    05
  6. Feb 05, 2026 · 16:53 · MYTC

    James Anderson Provides Update on Holdings of MyndTec Inc.

    James Anderson Provides Update on Holdings of MyndTec Inc.

    06
  7. Feb 05, 2026 · 16:30 · HBP

    Helix Biopharma Corp. Extends LEUMUNA Option with metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases

    Helix Biopharma Corp. Extends LEUMUNA Option with metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases

    07
  8. Feb 05, 2026 · 16:20 · MSCL

    Satellos Announces Launch of Public Offering in Canada and the United States and Filing of Application to List on Nasdaq

    Satellos Announces Launch of Public Offering in Canada and the United States and Filing of Application to List on Nasdaq

    08
  9. Feb 05, 2026 · 14:41 · BNXT

    Bionxt signs LOI for rights to drug chaperone technology

    Bionxt signs LOI for rights to drug chaperone technology

    09
  10. Feb 05, 2026 · 08:00 · PRN

    PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve(TM) Procedures, Expanding Access to Incision-Free Care for Women's Health

    PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve(TM) Procedures, Expanding Access to Incision-Free Care for Women's Health

    10
  11. Feb 05, 2026 · 04:33 · XRTX

    XORTX extends closing of therapeutic program buy

    XORTX extends closing of therapeutic program buy

    11
  12. Feb 05, 2026 · 03:05 · BNXT

    BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery

    BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery

    12
  13. Feb 04, 2026 · 20:07 · ADK

    Diagnos expects to receive $1M in federal investments

    Diagnos expects to receive $1M in federal investments

    13
  14. Feb 04, 2026 · 18:00 · XRTX

    XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

    XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

    14
← Newer Older →